2 news items
Qualigen Therapeutics' Novel Direct Pan-RAS Inhibitors Presented At American Association Of Cancer Research 2024 Annual Meeting
QLGN
10 Apr 24
community, where scientists, clinicians, other health care professionals, survivors, patients, and advocates gather to share the latest advances
Qualigen Therapeutics' Novel Direct Pan-RAS Inhibitors Presented at American Association of Cancer Research (AACR) 2024 Annual Meeting
QLGN
10 Apr 24
Conference is a focal point of the cancer research community, where scientists, clinicians, other health care professionals, survivors, patients, and advocates
- Prev
- 1
- Next